Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,849.20 +221.98 1.42%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,111.40 -53.97 -1.04%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Instruments

Thoratec Corp

+ Add to Watchlist

THOR:US

30.9700 USD 0.5500 1.74%

As of 20:10:00 ET on 05/22/2013.

Company Profile for Thoratec Corp (THOR)

Thoratec Corporation researches, develops, manufactures, and markets medical devices for circulatory support and vascular graft applications. The Company's products include a ventricular assist device, an implantable left ventricular heart assist device, a vascular access graft, and a coronary artery bypass graft. Thoratec also supplies whole-blood coagulation testing equipment.

Contact Information

Thoratec Corp

6035 Stoneridge Drive
Pleasanton, CA 94588
United States
Phone: 1-925-847-8600
Fax: 1-925-847-8574

Key Executives for Thoratec Corp (THOR)

Neil F DimickNon-Executive ChairmanGerhard F Burbach "Gary"President/CEO
David A LehmanSenior VP/Secy/Gen CnslTaylor C HarrisVP/CFO
Roxanne OulmanVP:Finance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil